CNSX:PMED

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Predictmedix Inc., an artificial intelligence (AI) company, develops technologies for impairment and healthcare. More Details


Snowflake Analysis

Flawless balance sheet with weak fundamentals.

Share Price & News

How has Predictmedix's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: PMED's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-16.7%

PMED

-7.3%

CA Electronic

-1.6%

CA Market


1 Year Return

n/a

PMED

-5.2%

CA Electronic

-8.0%

CA Market

Return vs Industry: Insufficient data to determine how PMED performed against the Canadian Electronic industry.

Return vs Market: Insufficient data to determine how PMED performed against the Canadian Market.


Shareholder returns

PMEDIndustryMarket
7 Day-16.7%-7.3%-1.6%
30 Day-33.3%-12.0%-3.8%
90 Day-28.6%0.3%5.1%
1 Yearn/a-5.2%-5.2%-4.8%-8.0%
3 Yearn/a-33.1%-33.1%6.5%-3.8%
5 Yearn/a-35.7%-35.7%39.2%17.9%

Price Volatility Vs. Market

How volatile is Predictmedix's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Predictmedix undervalued compared to its fair value and its price relative to the market?

36.56x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate PMED's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate PMED's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: PMED is unprofitable, so we can't compare its PE Ratio to the CA Electronic industry average.

PE vs Market: PMED is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate PMED's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: PMED is overvalued based on its PB Ratio (36.6x) compared to the CA Electronic industry average (5.4x).


Next Steps

Future Growth

How is Predictmedix forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

124.6%

Forecasted Tech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Predictmedix has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Predictmedix performed over the past 5 years?

-558.6%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: PMED is currently unprofitable.

Growing Profit Margin: PMED is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if PMED's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare PMED's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PMED is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (-20.5%).


Return on Equity

High ROE: PMED has a negative Return on Equity (-184.02%), as it is currently unprofitable.


Next Steps

Financial Health

How is Predictmedix's financial position?


Financial Position Analysis

Short Term Liabilities: PMED's short term assets (CA$1.4M) exceed its short term liabilities (CA$44.8K).

Long Term Liabilities: PMED has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: PMED is debt free.

Reducing Debt: PMED has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: PMED has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: PMED has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 69.2% each year.


Next Steps

Dividend

What is Predictmedix current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate PMED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PMED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PMED's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PMED's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of PMED's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.4yrs

Average board tenure


CEO

Predictmedix has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Rahul Kushwah
Director & COOno datano data7.93%
CA$ 4.0m
Ajit Kumar
Directorno datano datano data
Tomas Sipos
Directorno datano data0.25%
CA$ 125.0k
Navdeep Nanda
Member of Advisory Board0.42yrno datano data
Nitin Kadam
Member of Advisory Board0.42yrno datano data
Alexander Bardon
Member of Advisory Board0.42yrno datano data
Kapil Raval
Chairman of the Advisory Board0.33yrno datano data
Kiran Kumari
Member of Advisory Board0.083yrno datano data

0.4yrs

Average Tenure

Experienced Board: PMED's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: PMED only recently listed within the past 12 months.


Top Shareholders

Company Information

Predictmedix Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Predictmedix Inc.
  • Ticker: PMED
  • Exchange: CNSX
  • Founded:
  • Industry: Electronic Equipment and Instruments
  • Sector: Tech
  • Market Cap: CA$50.471m
  • Shares outstanding: 100.94m
  • Website: https://www.predictmedix.com

Location

  • Predictmedix Inc.
  • 77 King Street West
  • Suite 3000
  • Toronto
  • Ontario
  • M5K 1G8
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PMEDCNSX (Canadian National Stock Exchange)YesCommon SharesCACADDec 2019
PMED.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDDec 2019

Biography

Predictmedix Inc., an artificial intelligence (AI) company, develops technologies for impairment and healthcare. Its AI products use facial, thermal, video, and audio recognition technologies to determine ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/29 00:37
End of Day Share Price2020/09/28 00:00
Earnings2020/04/30
Annual Earnings2020/01/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.